{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dépréciation : Questions médicales les plus fréquentes",
"headline": "Dépréciation : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dépréciation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-16",
"dateModified": "2025-02-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dépréciation"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Comptabilité",
"url": "https://questionsmedicales.fr/mesh/D000066",
"about": {
"@type": "MedicalCondition",
"name": "Comptabilité",
"code": {
"@type": "MedicalCode",
"code": "D000066",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N03.219.463.030"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Dépréciation",
"alternateName": "Depreciation",
"code": {
"@type": "MedicalCode",
"code": "D003862",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Marcin Rzeszutek",
"url": "https://questionsmedicales.fr/author/Marcin%20Rzeszutek",
"affiliation": {
"@type": "Organization",
"name": "ªFaculty of Psychology, University of Warsaw, Stawki 5/7, 00-183, Warsaw, Poland."
}
},
{
"@type": "Person",
"name": "Richard G Tedeschi",
"url": "https://questionsmedicales.fr/author/Richard%20G%20Tedeschi",
"affiliation": {
"@type": "Organization",
"name": "Boulder Crest Institute for Posttraumatic Growth, Virginia, USA."
}
},
{
"@type": "Person",
"name": "Kanako Taku",
"url": "https://questionsmedicales.fr/author/Kanako%20Taku",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology."
}
},
{
"@type": "Person",
"name": "Małgorzata Pięta",
"url": "https://questionsmedicales.fr/author/Ma%C5%82gorzata%20Pi%C4%99ta",
"affiliation": {
"@type": "Organization",
"name": "ªFaculty of Psychology, University of Warsaw, Stawki 5/7, 00-183, Warsaw, Poland. mj.pieta@uw.edu.pl."
}
},
{
"@type": "Person",
"name": "Selina Platte",
"url": "https://questionsmedicales.fr/author/Selina%20Platte",
"affiliation": {
"@type": "Organization",
"name": "Institute for Medical Psychology, University Medicine Greifswald, Germany. Electronic address: Selina.Grunwald@uni-greifswald.de."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Control of drug release from cotton fabric by nanofibrous mat.",
"datePublished": "2022-06-24",
"url": "https://questionsmedicales.fr/article/35760164",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijbiomac.2022.06.138"
}
},
{
"@type": "ScholarlyArticle",
"name": "Foresee novel targets for Alzheimer's disease by investigating repurposed drugs.",
"datePublished": "2022-06-22",
"url": "https://questionsmedicales.fr/article/35733313",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2174/1871527321666220622162622"
}
},
{
"@type": "ScholarlyArticle",
"name": "Current emerging and investigational drugs for the treatment of chronic hand eczema.",
"datePublished": "2022-06-17",
"url": "https://questionsmedicales.fr/article/35658708",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13543784.2022.2087059"
}
},
{
"@type": "ScholarlyArticle",
"name": "Burnout and Engagement's Relationship to Drug Abuse in Lawyers and Law Professionals.",
"datePublished": "2022-06-16",
"url": "https://questionsmedicales.fr/article/35732047",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/JOM.0000000000002550"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diatomaceous earth as a drug-loaded carrier in a glass-ionomer cement.",
"datePublished": "2022-06-15",
"url": "https://questionsmedicales.fr/article/35738132",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jmbbm.2022.105324"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Organisations et économie des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D004472"
},
{
"@type": "ListItem",
"position": 3,
"name": "Économie",
"item": "https://questionsmedicales.fr/mesh/D004467"
},
{
"@type": "ListItem",
"position": 4,
"name": "Gestion financière",
"item": "https://questionsmedicales.fr/mesh/D005376"
},
{
"@type": "ListItem",
"position": 5,
"name": "Comptabilité",
"item": "https://questionsmedicales.fr/mesh/D000066"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dépréciation",
"item": "https://questionsmedicales.fr/mesh/D003862"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dépréciation - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dépréciation",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dépréciation",
"description": "Comment diagnostiquer la dépréciation fonctionnelle ?\nQuels tests sont utilisés pour évaluer la dépréciation ?\nQuels signes cliniques indiquent une dépréciation ?\nLa dépréciation peut-elle être mesurée ?\nQuels spécialistes évaluent la dépréciation ?",
"url": "https://questionsmedicales.fr/mesh/D003862?mesh_terms=Drug+Development&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dépréciation",
"description": "Quels sont les symptômes de la dépréciation ?\nLa dépréciation entraîne-t-elle des douleurs ?\nComment la dépréciation affecte-t-elle la mobilité ?\nY a-t-il des signes psychologiques associés ?\nLa dépréciation affecte-t-elle l'appétit ?",
"url": "https://questionsmedicales.fr/mesh/D003862?mesh_terms=Drug+Development&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dépréciation",
"description": "Comment prévenir la dépréciation ?\nLe dépistage précoce est-il important ?\nLes vaccinations aident-elles à prévenir la dépréciation ?\nLe soutien social joue-t-il un rôle ?\nLes habitudes de vie influencent-elles la dépréciation ?",
"url": "https://questionsmedicales.fr/mesh/D003862?mesh_terms=Drug+Development&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dépréciation",
"description": "Quels traitements sont disponibles pour la dépréciation ?\nLa nutrition joue-t-elle un rôle dans le traitement ?\nLes médicaments peuvent-ils aider ?\nLa thérapie physique est-elle efficace ?\nDes interventions chirurgicales sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D003862?mesh_terms=Drug+Development&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dépréciation",
"description": "Quelles complications peuvent survenir avec la dépréciation ?\nLa dépréciation peut-elle entraîner des maladies chroniques ?\nY a-t-il des risques de dépression ?\nLes complications affectent-elles la qualité de vie ?\nLa dépréciation peut-elle affecter la cognition ?",
"url": "https://questionsmedicales.fr/mesh/D003862?mesh_terms=Drug+Development&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dépréciation",
"description": "Quels sont les facteurs de risque de dépréciation ?\nLe sexe influence-t-il la dépréciation ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe niveau d'activité physique est-il un facteur ?\nLe statut socio-économique influence-t-il la dépréciation ?",
"url": "https://questionsmedicales.fr/mesh/D003862?mesh_terms=Drug+Development&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la dépréciation fonctionnelle ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des examens cliniques, des tests fonctionnels et des imageries."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la dépréciation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme la spirométrie, l'électromyographie et des bilans sanguins sont courants."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une dépréciation ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme la fatigue, la faiblesse musculaire et la perte de poids peuvent indiquer une dépréciation."
}
},
{
"@type": "Question",
"name": "La dépréciation peut-elle être mesurée ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des échelles de mesure comme l'échelle de Katz ou l'échelle de Barthel sont utilisées."
}
},
{
"@type": "Question",
"name": "Quels spécialistes évaluent la dépréciation ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les gériatres, les physiothérapeutes et les médecins généralistes sont souvent impliqués."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la dépréciation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la fatigue, la douleur, la perte de mobilité et la dépression."
}
},
{
"@type": "Question",
"name": "La dépréciation entraîne-t-elle des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la dépréciation peut causer des douleurs chroniques dues à des lésions tissulaires."
}
},
{
"@type": "Question",
"name": "Comment la dépréciation affecte-t-elle la mobilité ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut réduire la force musculaire et l'amplitude des mouvements, limitant la mobilité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes psychologiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété et la dépression sont fréquentes chez les personnes en dépréciation."
}
},
{
"@type": "Question",
"name": "La dépréciation affecte-t-elle l'appétit ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner une perte d'appétit et des troubles alimentaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dépréciation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une activité physique régulière, une alimentation saine et des bilans de santé réguliers aident."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce est-il important ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce permet d'identifier et de traiter les problèmes avant qu'ils ne s'aggravent."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir la dépréciation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent prévenir certaines infections qui aggravent la dépréciation."
}
},
{
"@type": "Question",
"name": "Le soutien social joue-t-il un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon soutien social peut améliorer la santé mentale et physique, réduisant la dépréciation."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles la dépréciation ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de vie saines comme ne pas fumer et limiter l'alcool sont bénéfiques."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la dépréciation ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la réhabilitation, la physiothérapie et des médicaments adaptés."
}
},
{
"@type": "Question",
"name": "La nutrition joue-t-elle un rôle dans le traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée est essentielle pour soutenir la santé et la récupération."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments anti-inflammatoires et des analgésiques peuvent soulager les symptômes."
}
},
{
"@type": "Question",
"name": "La thérapie physique est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie physique aide à améliorer la force et la fonction physique."
}
},
{
"@type": "Question",
"name": "Des interventions chirurgicales sont-elles possibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, des interventions chirurgicales peuvent être nécessaires pour corriger des dépréciations."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la dépréciation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des chutes, des fractures et une perte d'autonomie."
}
},
{
"@type": "Question",
"name": "La dépréciation peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut aggraver des maladies chroniques comme le diabète et les maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de dépression ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la dépréciation augmente le risque de dépression et d'anxiété chez les patients."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent significativement réduire la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "La dépréciation peut-elle affecter la cognition ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des troubles cognitifs et des problèmes de mémoire."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de dépréciation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge avancé, les maladies chroniques et le mode de vie sédentaire."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il la dépréciation ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines études montrent que les femmes peuvent être plus touchées par la dépréciation."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies peuvent augmenter le risque de dépréciation."
}
},
{
"@type": "Question",
"name": "Le niveau d'activité physique est-il un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un faible niveau d'activité physique est un facteur de risque majeur pour la dépréciation."
}
},
{
"@type": "Question",
"name": "Le statut socio-économique influence-t-il la dépréciation ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un statut socio-économique bas est souvent associé à une dépréciation accrue."
}
}
]
}
]
}
A drug delivery system (DDSs) was developed in the present study based on textile substrates as drug carriers and electrospun nanofibers as a controller of release rate. Three types of drugs consistin...
Alzheimer's Disease (AD) is the most rampant neurodegenerative disorder which has caused havoc worldwide. More than a century has passed since the first case of AD was reported, but still no stable tr...
Several drugs which were repurposed for AD were collected by following PRISMA 2020 systemic review. Databases like PubMed, ScienceDirect, JSTOR, and SciELO were used for data extraction. Further, Drug...
Drugs like Zileuton, Salbutamol, Baricitinib, Carmustine, Paclitaxel, and Nilotinib were observed to be involved in regulation of neurotransmitters. Similarly, Metformin, Liraglutide, UDCA, and Bexaro...
The study concluded that the reviewed drugs that follow similar biological and molecular processes can be repurposed for AD if chosen judiciously with current medications and thus drug repurposing is ...
Chronic hand eczema (CHE) is a highly prevalent, burdensome condition associated with functional impairment. Currently, topical therapeutics are the mainstay of CHE management. However, many cases are...
Following a brief overview of CHE pathogenesis and existing treatments, this review will outline the mechanisms and available data on emerging and investigational drugs currently being studied in clin...
Immunomodulatory drugs such as topical and systemic JAK inhibitors and Th2-targeting antibodies such as dupilumab are currently under investigation for CHE treatment, with early promise. Management of...
Investigate the associations between drug abuse and the prevalence of the engagement and burnout dichotomy in law professionals....
Eligible participants completed a questionnaire where odds ratios of drug abuse and other confounding variables and their association to engagement or burnout were calculated using multiple logistic r...
When looking at all law professionals, burnout is a statistically significant predictor for drug abuse ( P = 0.04, not shown). Law professionals whose burnout scores fell in the highest bin have 4.71 ...
Study findings showed a possible way to affect the prevalence of drug abuse in law professionals by affecting the engagement and burnout dichotomy....
The effect of a natural filler (diatomaceous earth [DE], a promising drug-delivery agent) and its content was investigated on the performance of a model glass-ionomer cement (GIC). Three sample series...
The last decade has seen development of numerous novel antipsychotic drugs with unique mechanisms including long-acting formulations for clinical use. A comparative assessment of these new drugs with ...
Medline was searched from January 2010 to February 2022 for primary research articles and review articles in English using the search terms "extrapyramidal" and "tardive" with individual drug names of...
We identified articles describing the risk of DIMD with 6 novel antipsychotics, 4 novel formulations, and 3 experimental antipsychotics. Both short- and long-term data generally showed comparable to l...
Several novel antipsychotics, particularly lumateperone and pimavanserin, show promise in being able to treat psychosis while reducing the risk of DIMD. Long-acting paliperidone may reduce risk of DIM...
Ventricular arrhythmias (Vas) are a life-threatening condition and preventable cause of sudden cardiac death (SCD). With the increased utilization of implantable cardiac defibrillators (ICD), the focu...
Infectious sequelae caused by surgery are a significant problem in modern medicine due to their reduction of therapeutic effectiveness and the patients' quality of life.Recently, new methods of local ...
Diabetes imposes a large burden on countries' healthcare expenditures. In Kuwait, diabetes prevalence in adults is estimated at 22.0%%-double the worldwide prevalence (9.3%). There is little current d...
Estimate the utilization and cost of drugs for diabetes and diabetes-related complications and comorbidities in Kuwait for year 2018, as well determinants of costs....
This cross-sectional study used a multi-stage stratified sampling method. Patients were Kuwaiti citizens with diabetes, aged 18-80, recruited from all six governorates. Physicians collected demographi...
Of 1182 diabetes patients, 64.0% had dyslipidemia and 57.7% had hypertension. Additionally, 40.7% had diabetes-related complications, most commonly neuropathy (19.7%). Of all diabetes patients, 85.9% ...
Drug costs for treating diabetes and comorbidities/complications accounted for an estimated 22.8% of Kuwait's 2018 drug expenditures. Comorbidities and complications add 44.7% to the average drug cost...
The polymers, chitosan, a polysaccharide, and gelatin, a protein, are crosslinked in different ratios without the aid of a crosslinking agent. Facile chemical reactions were followed to synthesize a c...